Hjem › Endometriekreft › California › San Diego
Kliniske studier for Endometriekreft i San Diego, CA
16 studier for Endometriekreft søker deltakere på steder i og rundt San Diego (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- UC San Diego Medical Center - Hillcrest, San Diego
- Sharp Memorial Hospital, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mi unna
DESTINY-PANTUMOUR04
RekruttererObservasjonsstudie
- Research Site, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- University of California, San Diego, La Jolla · 11 mi unna
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- Scripps Health, San Diego
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruttererFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mi unna
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
RekruttererFase 3
- Research Site, La Jolla · 11 mi unna
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RekruttererFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mi unna
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruttererFase 1
- UC San Diego Moores Cancer Center, San Diego
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
RekruttererFase 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi unna
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruttererFase 3
- Research Site, La Jolla · 11 mi unna
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Investigative Site #101, San Diego
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
RekruttererFase 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, La Jolla · 11 mi unna
A Beta-only IL-2 ImmunoTherapY Study
RekruttererFase 1/2
- Sharp Memorial Hospital, San Diego
Endometriekreft-studier i andre byer
- Houston, TX68 studier
- New York City, NY52 studier
- Boston, MA50 studier
- Arlington, VA39 studier
- Nashville, TN38 studier
- Los Angeles, CA34 studier
- St. Louis, MO29 studier
- Philadelphia, PA28 studier
- San Antonio, TX27 studier
- Queens, NY25 studier
- Oklahoma City, OK25 studier
- Chicago, IL25 studier
Andre studier i San Diego
- Ikke-småcellet lungekreft48 studier
- Brystkreft42 studier
- Kreft (alle typer)32 studier
- Prostatakreft31 studier
- Metastatisk kreft30 studier
- Kolorektal kreft25 studier
- Eggstokkreft24 studier
- Pankreaskreft24 studier
- Hjertesvikt23 studier
- Fedme23 studier
- Lungekreft23 studier
- Depresjon21 studier
Fra ClinicalTrials.gov, data hentet 7. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.